X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Organoids Companies (2024 - 2029)

Several companies are making significant strides in the field of organoid technology. These firms are advancing research and development systems, creating known medicine, and enhancing dynamic technologies. They are also focusing on the development of organoid technology, which is a significant breakthrough in the medical field. This innovation is a testament to the continued commitment of these corporations to push the boundaries of medical science and technology.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Biotechnology Research Equipment Research Emerging Technology Research Organoids Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Organoids Market

This report lists the top Organoids companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Organoids industry.

  1. Merck

  2. Cellesce

  3. 3Dnamics

  4. R&D Systems

  5. Hubrecht Organoid Technology

*Disclaimer: Top companies sorted in no particular order

Organoids Market Major Players

Organoids Market Concentration

Organoids Market Concentration

Organoids Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Research and Development Activity

      2. 4.2.2 Latest Advancement in Organoids

    3. 4.3 Market Restraints

      1. 4.3.1 Certain Charecteristics Differentiation with the Actual Organs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Intestine

      2. 5.1.2 Liver

      3. 5.1.3 Stomach

      4. 5.1.4 Pancrease

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Drug Discovery and Personalized Medicine

      2. 5.2.2 Drug Toxicity and Efficacy Testing

      3. 5.2.3 Regenerative Medicine

      4. 5.2.4 Developmental Biology

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Contract Research Organisations

      3. 5.3.3 Research Institutes

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Merck KGaA

      2. 6.1.2 Cellesce Ltd

      3. 6.1.3 3Dnamics Inc.

      4. 6.1.4 R&D Systems, Inc.

      5. 6.1.5 Hubrecht Organoid Technology

      6. 6.1.6 Definigen

      7. 6.1.7 Known Medicine

      8. 6.1.8 Dynomics Inc.

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Organoids Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Organoids Market Companies Summary

The Organoids Market, which is projected to register significant growth, has seen a substantial impact due to the COVID-19 pandemic. This has led to an increase in research and development activities, particularly in the creation of a COVID-19 vaccine. The use of organoids has become essential due to their resemblance to actual organs, cell tropism, and cell viability, among other factors. These factors have led to a significant increase in the adoption of organoids during drug development. The effectiveness of organoids in identifying treatment options for COVID-19 has also been reported, contributing to their increased use in the research field during the pandemic and beyond. In addition to the pandemic, the rising prevalence of chronic diseases and advancements in the development of organoids are driving the growth of the Organoids Market. The increasing number of patients suffering from chronic diseases has led to an increase in research and development initiatives for the introduction of novel drugs. As a result, the adoption of organoid models for R&D purposes is on the rise. Furthermore, initiatives in pharmaceutical research and development for the development of organoids and their application to different indications are also fueling the demand for organoids in the research field. Technological advancements in the development of organoids models are further improving the outcomes of organoids in pharmaceutical research.

Explore More

Organoids Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Merck KGaA

      2. 1.1.2 Cellesce Ltd

      3. 1.1.3 3Dnamics Inc.

      4. 1.1.4 R&D Systems, Inc.

      5. 1.1.5 Hubrecht Organoid Technology

      6. 1.1.6 Definigen

      7. 1.1.7 Known Medicine

      8. 1.1.8 Dynomics Inc.

    2. *List Not Exhaustive

Organoids Companies FAQs

Merck KGaA, Cellesce Ltd, 3Dnamics Inc., R&D Systems, Inc. and Hubrecht Organoid Technology are the major companies operating in the Organoids Market.

Organoids Report Snapshots

Organoids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)